Corient Private Wealth LP Acquires New Position in Astera Labs, Inc. $ALAB

Corient Private Wealth LP acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, HoldingsChannel reports. The firm acquired 21,270 shares of the company’s stock, valued at approximately $10,192,000.

A number of other large investors have also recently bought and sold shares of the business. BlackRock Inc. bought a new position in shares of Astera Labs during the second quarter valued at approximately $6,609,581,000. Atreides Management LP lifted its holdings in shares of Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares during the last quarter. State Street Corp lifted its holdings in shares of Astera Labs by 32.5% in the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after purchasing an additional 760,358 shares during the last quarter. Geode Capital Management LLC boosted its position in Astera Labs by 4.5% during the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after purchasing an additional 104,935 shares during the period. Finally, Bank of America Corp DE acquired a new position in Astera Labs during the 2nd quarter valued at approximately $1,061,791,000. Institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In related news, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total transaction of $4,047,300.00. Following the sale, the director directly owned 4,631 shares in the company, valued at $2,083,950. The trade was a 66.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the company’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the sale, the director directly owned 75,688 shares of the company’s stock, valued at $26,882,106.96. The trade was a 11.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 419,244 shares of company stock valued at $163,135,169. Company insiders own 10.40% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on ALAB shares. TD Cowen dropped their target price on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research report on Wednesday, August 5th. Needham & Company LLC boosted their price target on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Royal Bank Of Canada upped their price target on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Evercore restated an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. Finally, Barclays increased their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Astera Labs has an average rating of “Moderate Buy” and a consensus price target of $340.53.

Astera Labs Price Performance

Shares of ALAB stock opened at $289.47 on Friday. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The firm has a market capitalization of $50.22 billion, a price-to-earnings ratio of 143.30 and a beta of 3.84. The business has a 50 day simple moving average of $342.38 and a 200 day simple moving average of $249.65.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm’s revenue was up 104.5% compared to the same quarter last year. During the same period last year, the firm earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.